Top broker tips another 28% upside for the Allkem (ASX: AKE) share price

A miner in a hardhat makes a sale on his tablet in the field.A miner in a hardhat makes a sale on his tablet in the field.A miner in a hardhat makes a sale on his tablet in the field.

The Allkem Ltd (ASX: AKE) share price is gaining quietly today and, at the time of writing, is 0.36% higher at $9.735.

After a solid period last year, the Allkem share price is struggling in 2022, down 7% this year to date.

However, one broker is heavily bullish on the lithium company and reckons there’s plenty more upside potential for investors to bite into.

TradingView Chart

Can Allkem climb another 28% this year?

Analysts at Swiss investment bank UBS expect Allkem to deliver a strong result this year that should bode well for its share price.

The broker reckons Allkem will secure higher pricing for its lithium products and this should translate to higher earnings in 2022.

Considering that spodumene and lithium prices have soared 63% and 85% respectively this year already, the broker notes Allkem’s earnings should benefit.

Further, the company’s guidance on lithium carbonate pricing is for US$25,000 per tonne, a step ahead of the UBS forecast of US$23,000 a tonne.

This comes as Allkem renegotiated a one-third split in prices for its long-term carbonate contracts. This could lead to a phasing out of fixed prices.

UBS notes that Allkem’s “realisation is improving structurally” and that “spot prices are maintaining particularly high levels, which is likely to see strong upward moves in Allkem’s realised prices through the year”.

The Swiss broker is bullish on Allkem, rating it a buy and valuing the company at $12.40 per share. That signals a 28% upside potential at the time of writing.

Meanwhile, the bulk of analysts covering Allkem also have it as a buy with more than 83% of brokers urging their clients to purchase the stock, according to Bloomberg Intelligence. The consensus price target is $13.55.

This is substantially higher than for the same time last year. Then only 46% of analysts were saying to buy the stock and 7% were advising to sell.

As of today, there are no brokers advocating to sell Allkem, according to Bloomberg.

Allkem share price snapshot

In the last 12 months, the Allkem share price has surged more than 114% but has faltered almost 7% this year to date.

During the past month though, the company’s shares have reversed course after adding almost 11% in gains during the past week of trading.

The post Top broker tips another 28% upside for the Allkem (ASX: AKE) share price appeared first on The Motley Fool Australia.

Should you invest $1,000 in Allkem right now?

Before you consider Allkem, you’ll want to hear this.

Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Allkem wasn’t one of them.

The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

*Returns as of January 13th 2022

More reading

Motley Fool contributor Zach Bristow has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/1xZL8pK

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *